Search - tctmd.com

Displaying 721 - 740 of 7408

Sort: Relevancy | Date

Presentation TCT 2023

TCT 424: In Vitro Investigation of Polymer Damage on Drug-Eluting Stents Resulting from Intravascular Lithotripsy

Presenter: Doosup Shin

October 25, 2023

Presentation TCT 2023

TCT 220: Stent Elongation in-Vivo is Mediated by Lesion Morphology as Defined by OCT.

Presenter: Michael McGarvey

October 25, 2023

Presentation TCT 2023

TCT 956: ´´Only Steel can Heal´´ Retrograde stenting of the left main after double chimney stenting in TAVR-in-TAVR-in-SAVR

Presenter: Kambis Mashayekhi

October 25, 2023

Presentation TCT 2023

TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers

Presenter: Eline Ploumen

October 25, 2023

Presentation TCT 2023

What to Do When Iliocaval Stents Fail

Presenter: Pallav Kolli

October 25, 2023

Presentation TCT 2023

Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial

Presenter: Juan Iglesias

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

Presentation TCT 2023

TCT 514: Safety and Efficacy of 19 different Stent Strategies in Percutaneous Coronary Intervention. A Trial-Sequential, Influential, Bivariate and Network Meta-Analysis

Presenter: Harigopal Sandhyavenu

October 25, 2023

Presentation TCT 2023

TCT 466: Unintended deformation of stents during bifurcation PCI. An OCTOBER trial substudy

Presenter: Lene Andreasen

October 25, 2023

Presentation TCT 2023

Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial

Presenter: Giovanni Esposito

October 25, 2023

Presentation TCT 2023

TCT 949: Second layered stent implantation improved overall stent expansion for acute left main trunk occlusion following transcatheter aortic valve replacement

Presenter: Shinichiro Yamada

October 25, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

Presentation TCT 2023

TCT 936: Coronary pseudoaneurysm secondary to Papyrus covered stent rupture.

Presenter: Pilar Roquero Giménez

October 25, 2023

News Conference News TCT 2023

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Caitlin E. Cox

October 25, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

Presentation TCT 2023

TCT 935: Retrograde fenestration of a covered stent after Left main-left anterior descending perforation

Presenter: Salvatore Colangelo

October 25, 2023

Presentation TCT 2023

TCT 354: The clinical impact of Dual Antiplatelet Therapy score combined with P2Y12 reactivity unit on East Asian patients who received drug eluting stent implantation; PTRG-DES Consortium

Presenter: Seong Huan Choi

October 25, 2023

Presentation TCT 2023

The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration

Presenter: Pieter Smits

October 25, 2023

Presentation TCT 2023

TCT 954: High Risk Left Main Stenting through EVOLUT Valve with Impella Support from Axillary Access

Presenter: Sze Jia Ng

October 25, 2023

Presentation TCT 2023

TCT 30: Predicting Individual Treatment Effects to Determine Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

Presenter: Byeong-Keuk Kim

October 25, 2023

Advertisement

TCT 424: In Vitro Investigation of Polymer Damage on Drug-Eluting Stents Resulting from Intravascular Lithotripsy

TCT 220: Stent Elongation in-Vivo is Mediated by Lesion Morphology as Defined by OCT.

TCT 956: ´´Only Steel can Heal´´ Retrograde stenting of the left main after double chimney stenting in TAVR-in-TAVR-in-SAVR

TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers

What to Do When Iliocaval Stents Fail

Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

TCT 514: Safety and Efficacy of 19 different Stent Strategies in Percutaneous Coronary Intervention. A Trial-Sequential, Influential, Bivariate and Network Meta-Analysis

TCT 466: Unintended deformation of stents during bifurcation PCI. An OCTOBER trial substudy

Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial

TCT 949: Second layered stent implantation improved overall stent expansion for acute left main trunk occlusion following transcatheter aortic valve replacement

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

TCT 936: Coronary pseudoaneurysm secondary to Papyrus covered stent rupture.

Comparing DCBs in De Novo CAD: Drugs, Design Matter

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

TCT 935: Retrograde fenestration of a covered stent after Left main-left anterior descending perforation

TCT 354: The clinical impact of Dual Antiplatelet Therapy score combined with P2Y12 reactivity unit on East Asian patients who received drug eluting stent implantation; PTRG-DES Consortium

The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration

TCT 954: High Risk Left Main Stenting through EVOLUT Valve with Impella Support from Axillary Access

TCT 30: Predicting Individual Treatment Effects to Determine Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content